4.0 Article

Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: Association with the functional IRAK1 196Phe/532Ser haplotype

期刊

ARTHRITIS AND RHEUMATISM
卷 63, 期 12, 页码 3979-3987

出版社

WILEY
DOI: 10.1002/art.30640

关键词

-

资金

  1. Agence Nationale de la Recherche [R070994KS]
  2. Societe Francaise de Rhumatologie
  3. Association des Sclerodermiques de France
  4. Groupe Francais de Recherche sur la Sclerodermie
  5. INSERM
  6. German Federal Ministry for Education and Research [01 GM 0310, 01 GM 0634]
  7. Helmholtz Zentrum Munchen-German Research Center for Environmental Health, Neuherberg, Germany
  8. German National Genome Research Network [01GS0834]
  9. University of Ulm
  10. Ludwig-Maximilian University Munich (LMU, Munich Center of Health Sciences)
  11. European Union [HEALTH-F4-2007-201550]
  12. Actelion
  13. GlaxoSmithKline
  14. BSP Pharma
  15. Celgene

向作者/读者索取更多资源

Objective Several autoimmune disorders, including systemic sclerosis (SSc), are characterized by a strong sex bias. To date, it is not known whether genes on the sex chromosomes influence SSc susceptibility. Recently, an IRAK1 haplotype that contains the 196Phe functional variant (rs1059702), located on Xq28, was found to confer susceptibility to systemic lupus erythematosus (SLE). This study was undertaken to test for an association between SSc and the IRAK1 SLE risk haplotype. Methods. We tested for an association with the IRAK1 SLE risk haplotype in a discovery set of 849 SSc patients and 625 controls. IRAK1 rs1059702 was further genotyped in a replication set, which included Caucasian women from Italy (493 SSc patients and 509 controls) and Germany (466 SSc patients and 1,083 controls). Results. An association between the IRAK1 haplotype and SSc was detected in the discovery set. In both the discovery and replication sets, the rs1059702 TT genotype was found to be associated with specific SSc subsets, highlighting a potential contribution to disease severity. A meta-analysis provided evidence of an association of both the T allele and TT genotype with the overall disease, with an odds ratio (OR) of 1.20 and 95% confidence interval (95% CI) of 1.06- 1.35 for the T allele (P = 0.003) and an OR of 1.49 and 95% CI of 1.06- 2.10 for the TT genotype (P = 0.023). However, the most notable associations were observed with the diffuse cutaneous, anti- topoisomerase I antibody positive, and SSc-related fibrosing alveolitis subsets (OR 2.35 [95% CI 1.51- 3.66], P = 1.56 x 10(-4), OR 2.84 [95% CI 1.87- 4.32], P = 1.07 x 10(-6), and OR 2.09 [95% CI 1.35- 3.24], P = 9.05 x 10(-4), respectively). Conclusion. Our study provides the first evidence of an association between IRAK1 and SSc, demonstrating that a sex chromosome gene directly influences SSc susceptibility and its phenotypic heterogeneity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rheumatology

Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort

Michael Hughes, Suiyuan Huang, Juan Jose Alegre-Sancho, Patricia E. Carreira, Merete Engelhart, Eric Hachulla, Joerg Henes, Eduardo Kerzberg, Maria Rosa Pozzi, Gabriela Riemekasten, Vanessa Smith, Gabriella Szucs, Marie Vanthuyne, Elisabetta Zanatta, Oliver Distler, Armando G. Gabrielli, Anna-Maria Hoffmann-Vold, Virginia D. Steen, Dinesh Khanna

Summary: This study aimed to investigate the prevalence and characteristics of late skin fibrosis in systemic sclerosis (SSc). The study found that late skin fibrosis is not uncommon in SSc, and different patterns of development exist among patients. Patients with lower baseline mRSS and lcSSc are more likely to develop late skin fibrosis. Anti-Scl-70 is associated with progression from lcSSc to dcSSc, while anticentromere antibodies have a protective effect.

RHEUMATOLOGY (2023)

Article Rheumatology

Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease

Cosimo Bruni, Mariaelena Occhipinti, Michael Pienn, Gianna Camiciottoli, Maurizio Bartolucci, Silvia Laura Bosello, Christian Payer, Zoltan Balint, Anna Rita Larici, Alessandra Tottoli, Lorenzo Tofani, Enrico De Lorenzis, Gemma Lepri, Silvia Bellando-Randone, Amelia Spinella, Dilia Giuggioli, Francesco Masini, Giovanna Cuomo, Federico Lavorini, Stefano Colagrande, Horst Olschewski, Marco Matucci-Cerinic

Summary: Recent advancements have made it possible to quantitatively assess lung vascular and parenchymal changes in thoracic CT images using automated software tools. In this study, the researchers investigated the vessel parameters of patients with SSc and correlated them with interstitial lung disease (ILD) features. The results showed that the CT vessel parameters increased in parallel with ILD extent and functional impairment, suggesting that they may serve as a biomarker of SSc-ILD severity.

RHEUMATOLOGY (2023)

Article Rheumatology

Determination of four homogeneous subgroups of patients with antiphospholipid syndrome: a cluster analysis based on 509 cases

Yann Nguyen, Cecile M. Yelnik, Nathalie Morel, Romain Paule, Romain Stammler, Leo Placais, Karim Sacre, Bertrand Godeau, Helene Maillard, David Launay, Sandrine Morell-Dubois, Anastasia Dupre, Guillaume Lefevre, Cecile Devloo, Virginie Dufrost, Ygal Benhamou, Herve Levesque, Gaelle Leroux, Jean-Charles Piette, Luc Mouthon, Eric Hachulla, Marc Lambert, Veronique Le Guern, Nathalie Costedoat-Chalumeau

Summary: This study used unsupervised clustering analysis to identify four homogeneous phenotypic subgroups among APS patients, primarily involving venous, arterial, SLE or other autoimmune disease-associated, and arterial microthrombotic phenotypes. These findings may be explained by heterogeneous pathophysiological mechanisms.

RHEUMATOLOGY (2023)

Article Rheumatology

Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database

Michele Iudici, Denis Mongin, Elise Siegert, Patricia E. Carreira, Joerg Distler, Joerg Henes, Elisabetta Zanatta, Eric Hachulla, Giacomo De Luca, Carolina de Souza Mueller, Tania Santiago, Jose-Luis Tandaipan, Breno Valdetaro Bianchi, Maria De Santis, Anna-Maria Hoffmann-Vold, Armando Gabrielli, Oliver Distler, Delphine Sophie Courvoisier

Summary: The study aimed to estimate the prevalence of long-term exposure to glucocorticoids (GCs) among SSc patients and identify factors associated with prescribing practices over time and across countries. The results showed that the utilization of GCs is widespread and long-term in SSc patients, with significant variations between countries and within-country. However, there has been a gradual decrease in their utilization.

RHEUMATOLOGY (2023)

Article Rheumatology

Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region

Alain Lescoat, Doerte Huscher, Nils Schoof, Paolo Airo, Jeska De Vries-Bouwstra, Gabriela Riemekasten, Eric Hachulla, Andrea Doria, Edoardo Rosato, Nicolas Hunzelmann, Carlomaurizio Montecucco, Armando Gabrielli, Anna-Maria Hoffmann-Vold, Oliver Distler, Jennifer Ben Shimol, Maurizio Cutolo, Yannick Allanore

Summary: The prevalence and characteristics of SSc-associated interstitial lung disease (SSc-ILD) vary between geographical regions. This study aimed to explore the differences in prevalence, phenotype, treatment, and prognosis in patients with SSc-ILD from different regions in the EUSTAR database. The results showed significant variations in clinical characteristics, survival rates, and treatment approaches among different regions.

RHEUMATOLOGY (2023)

Article Clinical Neurology

Integrative miRNA-mRNA profiling of human epidermis: unique signature of SCN9A painful neuropathy

Mirna Andelic, Erika Salvi, Stefania Marcuzzo, Margherita Marchi, Raffaella Lombardi, Daniele Cartelli, Daniele Cazzato, Elkadia Mehmeti, Andrea Gelemanovic, Matilde Paolini, Carlotta Pardo, Ilaria D'Amato, Janneke G. J. Hoeijmakers, Sulayman Dib-Hajj, Stephen G. Waxman, Catharina G. Faber, Giuseppe Lauria

Summary: Personalized management of neuropathic pain is a clinical need that has not been fulfilled due to various factors. Recent studies on microRNA have provided insights into pain-related mechanisms and identified potential drug candidates. By generating a molecular profile of the epidermis in patients with sodium channel-related painful neuropathy, the researchers identified specific miRNAs and mRNA targets that are involved in peripheral sensory transduction and modulation. The findings suggest a complex interaction between epidermal cells and axons in neuropathy pain. This targeted molecular profiling could advance personalized medicine for neuropathic pain.
Article Cardiac & Cardiovascular Systems

Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods

Betul Toprak, Stephanie Brandt, Jan Brederecke, Francesco Gianfagna, Julie K. K. Vishram-Nielsen, Francisco M. Ojeda, Simona Costanzo, Christin S. Borschel, Stefan Soderberg, Ioannis Katsoularis, Stephan Camen, Erkki Vartiainen, Maria Benedetta Donati, Jukka Kontto, Martin Bobak, Ellisiv B. Mathiesen, Allan Linneberg, Wolfgang Koenig, Maja-Lisa Lochen, Augusto Di Castelnuovo, Stefan Blankenberg, Giovanni de Gaetano, Kari Kuulasmaa, Veikko Salomaa, Licia Iacoviello, Teemu Niiranen, Tanja Zeller, Renate B. Schnabel

Summary: The study aims to find reliable circulating predictors for incident atrial fibrillation (AF) using classical regressions and machine learning techniques. Fourteen routinely available biomarkers reflecting different pathophysiological pathways were examined in relation to incident AF. NT-proBNP was identified as the strongest blood-based predictor of incident AF.

EUROPACE (2023)

Article Cardiac & Cardiovascular Systems

Inclisiran and cardiovascular events: a patient-level analysis of phase III trials

Kausik K. Ray, Frederick J. Raal, David G. Kallend, Mark J. Jaros, Wolfgang Koenig, Lawrence A. Leiter, Ulf Landmesser, Gregory G. Schwartz, David Lawrence, Andrew Friedman, Lorena Garcia Conde, R. Scott Wright

Summary: Exploratory findings from the ORION trials suggest that treatment with inclisiran is associated with reductions in major cardiovascular events, providing potential cardiovascular benefits.

EUROPEAN HEART JOURNAL (2023)

Article Biochemistry & Molecular Biology

Metabolic Signatures Elucidate the Effect of Body Mass Index on Type 2 Diabetes

Qiuling Dong, Sidra Sidra, Christian Gieger, Rui Wang-Sattler, Wolfgang Rathmann, Cornelia Prehn, Jerzy Adamski, Wolfgang Koenig, Annette Peters, Harald Grallert, Sapna Sharma

Summary: Obesity is closely related to insulin resistance and diabetes, but the specific molecular mechanism that links these conditions remains unclear. This study analyzed the metabolomic profiles of a cohort of 1715 participants and found significant associations between certain metabolites and both obesity and type 2 diabetes. Further analysis suggested that lipids such as sphingomyelin and diacylphosphatidylcholine may mediate the effect of obesity on diabetes. Additionally, genetic research and experiments with mice supported the hypothesis that changes in sphingolipid and phosphatidylcholine metabolism contribute to the development of early-stage type 2 diabetes.

METABOLITES (2023)

Article Immunology

COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection

Cloe Comarmond, Elodie Drumez, Julien Labreuche, Eric Hachulla, Thierry Thomas, Rene-Marc Flipo, Raphaelle Seror, Jerome Avouac, Nathalie Balandraud, Renaud Desbarbieux, Renaud Felten, Melanie Gilson, Marie-Hlene Guyot, Ambre Hittinger-Roux, Thao Pham, Myriam Renard, Nicolas Roux, Vincent Sobanski, Anne Tournadre, Christophe Richez, Patrice Cacoub

Summary: This study investigated whether RMD patients receiving anti-IL6 therapy have less severe forms of COVID-19 and better outcomes. Retrospective analysis of the French RMD COVID-19 cohort data showed that the severity of COVID-19 was lower in the anti-IL6 group, but there were no significant differences in the evolution of COVID-19 between the groups.

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2023)

Article Anesthesiology

TRPA1 rare variants in chronic neuropathic and nociplastic pain patients

Margherita Marchi, Erika Salvi, Mirna Andelic, Elkadia Mehmeti, Ilaria D'Amato, Daniele Cazzato, Federica Chiappori, Raffaella Lombardi, Daniele Cartelli, Grazia Devigili, Eleonora Dalla Bella, Monique Gerrits, Rowida Almomani, Rayaz A. Malik, Milena Sleczkowska, Anna Mazzeo, Luca Gentile, Sulayman Dib-Hajj, Stephen G. Waxman, Catharina G. Faber, Eleonora Vecchio, Marina de Tommaso, Giuseppe Lauria

Summary: This study aimed to identify rare variants associated with chronic neuropathic pain and nociplastic pain by conducting next-generation sequencing and gene-wise aggregation analysis. TRPA1 was found to be the most significant gene, with the frequency of rare variants significantly differentiating chronic pain patients from healthy controls. The study expands the understanding of channelopathy-related chronic pain disorders and contributes to personalized therapies based on patients' molecular profiles.
Article Cardiac & Cardiovascular Systems

Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitus

Paul M. Haller, Alina Gossling, Christina Magnussen, Hermann Brenner, Ben Schoettker, Licia Iacoviello, Simona Costanzo, Frank Kee, Wolfgang Koenig, Allan Linneberg, Chaterina Sujana, Barbara Thorand, Veikko Salomaa, Teemu J. Niiranen, Stefan Soederberg, Henry Voelzke, Marcus Doerr, Susana Sans, Teresa Padro, Stephan B. Felix, Matthias Nauck, Astrid Petersmann, Luigi Palmieri, Chiara Donfrancesco, Roberto De Ponti, Giovanni Veronesi, Marco M. Ferrario, Kari Kuulasmaa, Tanja Zeller, Francisco M. Ojeda, Stefan Blankenberg, Dirk Westermann

Summary: This study demonstrates the role of cardiac biomarkers in predicting cardiovascular events and death in both general population and individuals with known diabetes. The findings suggest that these biomarkers can help identify individuals at highest risk for cardiovascular events and improve early identification of high-risk individuals. Therefore, they should be considered for routine risk assessment and can enhance the initiation of preventive therapies.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Critical Care Medicine

Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research

Anna -Maria Hoffmann-Vold, Cathrine Brunborg, Paolo Airo, Lidia P. Ananyeva, Laszlo Czirjak, Serena Guiducci, Eric Hachulla, Mengtao Li, Carina Mihai, Gabriela Riemekasten, Petros P. Sfikakis, Gabriele Valentini, Otylia Kowal-Bielecka, Yannick Allanore, Oliver Distler

Summary: This study aimed to test whether enrichment strategies from clinical trials for progressive systemic sclerosis-associated interstitial lung disease (SSc-ILD) affect efficacy, representativeness, and feasibility. The researchers applied the inclusion criteria of major recent SSc-ILD trials to patients with SSc-ILD from the European Scleroderma Trials and Research (EUSTAR) database. The results showed that patient populations that fulfilled different study inclusion criteria significantly differed in various clinical parameters, and the application of enrichment criteria did not have a significant impact on ILD progression.
Meeting Abstract Rheumatology

MUSCLE INVOLVEMENT IN SYSTEMIC SCLEROSIS: REVISITING THE CLASSIFICATION IN LIGHT OF AUTOMATED MORPHOMETRY

Louai Zaidan, Noemie Le Gouellec, Eric Hachulla, Luc Mouthon, Francois Jerome Authier

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

Article Rheumatology

Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort

E. Gremese, Francesco Ciccia, Carlo Selmi, Giovanna Cuomo, Rosario Foti, Marco Matucci-Cerinic, Fabrizio Conti, Enrico Fusaro, Giuliana Guggino, Florenzo Iannone, Andrea Delle Sedie, Roberto Perricone, Luca Idolazzi, Paolo Moscato, Elke Theander, Wim Noel, Paul Bergmans, Silvia Marelli, Laure Gossec, Josef S. Smolen

Summary: This study compared the real-world persistence, effectiveness, and tolerability of ustekinumab and TNFi in PsA patients. The results showed that ustekinumab had better persistence than TNFi, overall and in specific subgroups. After one year of treatment, both ustekinumab and TNFi showed similar effectiveness.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

暂无数据